Price
No data yet.
Social Signal Score
Revenue
$109.45M+232.40%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Oguzhan Atay
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 713
- Beta
- 0.34
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 14.83
Financials
BLLN has only 10 quarterly periods on file — the charts below show the full history available.
Revenue
$109.45M+232.4%Net Income
$8.05MEBITDA
$10.92MFree Cash Flow
$5.09MEPS (diluted)
$0.15Shares Outstanding (diluted)
54.46M+21.8%Operating Expenses
$71.60MCash & Debt
$548.63MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $305.11M | $7.45M | $0.06 |
| 2024 | $152.58M | $-41.57M | $-0.93 |
| 2023 | $71.73M | $-82.68M | $-1.85 |
Valuation
Project earnings forward and see what return today's price implies.
EPS was negative in at least one boundary year, so a compound growth rate can't be computed from it. Set your own assumption.
- EPS in 5 years
- $0.24
- Implied price
- $4.30
- Return from $93.29
- -45.9% a year
To earn 15.0% a year on these assumptions you'd need to buy at $2.14 — -97.7% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| -2.0% | -54.8% | -52.7% | -51.0% | -49.4% | -48.0% |
| 3.0% | -52.5% | -50.3% | -48.5% | -46.8% | -45.4% |
| 8.0% | -50.2% | -47.9% | -45.9% | -44.3% | -42.7% |
| 13.0% | -47.9% | -45.5% | -43.4% | -41.7% | -40.1% |
| 18.0% | -45.5% | -43.1% | -40.9% | -39.1% | -37.4% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
80Social Signal Score
Mentions (1)
- Newsfool.com·6h ago·Negative
BillionToOne's Co-Founder Sells 10,000 Shares for $1 Million The transaction involved 10,000 shares at a weighted-average price of $100.00 per share, totaling $1.0 million on the August 25, 2026 transaction date. Following the disposal, the insider holds a direct position of 1,000 shares, which represents approximately 0.0022% of the company's total shares outstanding.
View source ↗
Earnings
Tue, Oct 6(in 5 weeks)
Consensus estimate $0.15 per share
Typical surprise -18.2% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 5$0.15 vs $0.18miss
- Wed, May 6$0.34 vs $0.01beat
- Wed, Mar 4$0.11 vs $0.07beat
- Tue, Dec 9$0.10 vs $0.14miss
- Tue, Oct 7$-0.02 vs $0.14miss
Estimates and results for BLLN via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.